Christoph Liebetrau Selected Research

Indicators and Reagents (Reagents)

8/2020	Pregnancy-associated plasma protein A - a new indicator of pulmonary vascular remodeling in chronic thromboembolic pulmonary hypertension?
1/2016	Effect of Renal Sympathetic Denervation on Specific MicroRNAs as an Indicator of Reverse Remodeling Processes in Hypertensive Heart Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christoph Liebetrau Research Topics

Disease

40	Myocardial Infarction 11/2022 - 06/2012
31	Acute Coronary Syndrome 11/2022 - 07/2011
23	Hemorrhage 11/2022 - 03/2016
22	Pulmonary Hypertension 01/2022 - 12/2014
17	Thrombosis (Thrombus) 03/2022 - 02/2014
15	Aortic Valve Stenosis (Aortic Stenosis) 12/2022 - 12/2013
14	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021 - 09/2010
13	Stroke (Strokes) 12/2021 - 12/2016
10	Hypertrophy 01/2021 - 06/2012
9	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 02/2011
9	Inflammation (Inflammations) 08/2020 - 09/2010
9	Hypertension (High Blood Pressure) 01/2018 - 10/2013
8	ST Elevation Myocardial Infarction 11/2021 - 03/2011
8	Heart Failure 10/2021 - 03/2012
7	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 12/2017 - 06/2012
4	Vascular Remodeling 08/2020 - 05/2014
4	Infarction (Infarctions) 07/2019 - 03/2016
3	Cardiomyopathies (Cardiomyopathy) 01/2022 - 01/2021
3	Pulmonary Arterial Hypertension 01/2021 - 11/2015
3	Bundle-Branch Block (Fascicular Block) 01/2021 - 01/2018
3	Acute Kidney Injury (Acute Renal Failure) 12/2020 - 08/2013
3	Bicuspid Aortic Valve Disease 02/2020 - 06/2019
3	Ischemia 01/2020 - 05/2016
3	Heart Diseases (Heart Disease) 10/2019 - 12/2015
3	Fibrosis (Cirrhosis) 08/2019 - 03/2012
3	Heart Arrest (Cardiac Arrest) 01/2019 - 03/2013
3	Chest Pain (Chest Pains) 01/2019 - 07/2011
3	Neoplasms (Cancer) 10/2018 - 02/2017
3	Vascular Diseases (Vascular Disease) 01/2018 - 11/2015
2	Atrial Fibrillation 03/2022 - 07/2015
2	Cardiogenic Shock 03/2022 - 03/2011
2	Right Ventricular Dysfunction 01/2022 - 10/2021
2	Out-of-Hospital Cardiac Arrest 12/2021 - 09/2013
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 05/2020 - 11/2019
2	Non-ST Elevated Myocardial Infarction 01/2020 - 07/2017
2	Pulmonary Embolism 01/2020 - 08/2019
2	Pathologic Constriction (Stenosis) 11/2014 - 02/2011
1	Ischemic Stroke 03/2022
1	Aneurysm (Aneurysms) 11/2021
1	Left Ventricular Dysfunction 06/2021
1	Systolic Heart Failure 06/2021
1	COVID-19 01/2021
1	No-Reflow Phenomenon 01/2021
1	Sepsis (Septicemia) 01/2021
1	Renal Insufficiency (Renal Failure) 01/2021

Drug/Important Bio-Agent (IBA)

25	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2012
16	TicagrelorIBA 11/2022 - 03/2016
10	TroponinIBA 12/2021 - 02/2014
10	Troponin T (Troponin T1)IBA 07/2019 - 07/2011
8	Prasugrel Hydrochloride FDA Link 11/2022 - 10/2019
7	omega-Chloroacetophenone (Mace)IBA 01/2021 - 02/2015
7	Troponin IIBA 01/2020 - 03/2015
6	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 11/2022 - 01/2019
6	Clopidogrel (Plavix)FDA Link 11/2022 - 03/2016
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2022 - 02/2017
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
4	Galectin 3 (LGALS3)IBA 01/2021 - 09/2018
4	MicroRNAs (MicroRNA)IBA 01/2019 - 09/2010
3	Proton Pump InhibitorsIBA 10/2018 - 03/2016
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018 - 02/2014
3	Everolimus FDA Link 01/2017 - 02/2014
3	CollagenIBA 11/2015 - 03/2012
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2022 - 01/2019
2	CreatinineIBA 01/2022 - 01/2018
2	OsteopontinIBA 01/2021 - 08/2019
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 01/2014
2	Lipocalin-2IBA 12/2020 - 08/2013
2	Indicators and Reagents (Reagents)IBA 08/2020 - 01/2016
2	Angiotensin Receptor AntagonistsIBA 02/2020 - 10/2018
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2020 - 10/2018
2	trans-crotonin (CTN)IBA 09/2019 - 02/2014
2	Matrix Metalloproteinases (MMPs)IBA 04/2018 - 02/2015
2	Peptides (Polypeptides)IBA 05/2017 - 10/2015
2	CytokinesIBA 05/2016 - 03/2012
2	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 11/2015 - 04/2014
2	C-Reactive ProteinIBA 02/2015 - 02/2015
2	Interleukin-6 (Interleukin 6)IBA 02/2015 - 02/2015
1	Angiopoietin-2IBA 12/2021
1	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 11/2021
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 01/2021
1	Contrast MediaIBA 01/2021

Therapy/Procedure

28	Therapeutics 11/2022 - 03/2011
27	Percutaneous Coronary Intervention 03/2022 - 02/2011
18	Transcatheter Aortic Valve Replacement 12/2022 - 12/2013
13	Stents 03/2022 - 02/2011
7	Endarterectomy (Thromboendarterectomy) 01/2022 - 12/2014
6	Sympathectomy (Sympathectomies) 01/2016 - 10/2013
4	Prostheses and Implants (Prosthesis) 01/2020 - 11/2014
3	Blood Transfusion (Blood Transfusions) 01/2018 - 10/2016
3	Cardiopulmonary Resuscitation (CPR) 11/2016 - 03/2011
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 05/2015 - 02/2011
2	Drug-Eluting Stents 01/2022 - 02/2014
2	Critical Care (Surgical Intensive Care) 12/2021 - 01/2019
2	Length of Stay 01/2021 - 12/2016
2	Catheters 10/2017 - 06/2017
2	Extracorporeal Membrane Oxygenation 11/2016 - 09/2013
1	Resuscitation 03/2022
1	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2021
1	Ligation 12/2021
1	Punctures 08/2021